Worldwide Prescription Drug Sales to Exceed Trillion Dollar Mark by 2020

Industry to grow, on average, 5.1 percent per year from 2013 to 2020

26-Jun-2014 - United Kingdom

Record breaking new drug approvals, a hefty product pipeline and dramatically improved R&D productivity that has kept expenditure growth below sales growth prove that the industry is turning a new corner according to Evaluate’s, “World Preview 2014, Outlook to 2020” report.

“This much improved growth outlook comes as welcome news after two years of actual sales stagnation,” said Paul Hills, report author and Evaluate’s head of operations. “While the patent cliff is now but a distant memory, a new debate over drug pricing is stirring up controversy. This will only intensify as the industry continues to shift away from primary care and new technology waves offer innovative products that potentially take costs out of healthcare.”

Other news from the department business & finance

More news from our other portals

All FT-IR spectrometer manufacturers at a glance